Market Cap 2.50B
Revenue (ttm) 14.75M
Net Income (ttm) -413.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,803.80%
Debt to Equity Ratio 0.00
Volume 7,056,800
Avg Vol 9,162,860
Day's Range N/A - N/A
Shares Out 882.62M
Stochastic %K 26%
Beta 0.08
Analysts Strong Sell
Price Target $11.40

Company Profile

ImmunityBio, Inc., a commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead b...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 696 5235
Address:
3530 John Hopkins Court, San Diego, United States
arnolddunn
arnolddunn Jul. 19 at 6:16 PM
$IBRX guess bulls have been spoofing each other a long time.
0 · Reply
david756
david756 Jul. 19 at 5:30 PM
$NLST Same crap going on with shorts coping accounts and following on the $IBRX board
0 · Reply
BixbyKnolls
BixbyKnolls Jul. 19 at 4:57 PM
$IBRX Perhaps BioShield can save healthcare in our country. Conservative IBD. Going to hurt the maga base along with many of us? https://www.investors.com/news/big-beautiful-bill-trump-budget-health-care-coverage/
0 · Reply
John_morris
John_morris Jul. 19 at 3:30 PM
$IBRX Sharing https://x.com/GretchMick/status/1946578408399651138
1 · Reply
Jhankster60
Jhankster60 Jul. 19 at 3:25 PM
$IBRX There’s an imposter out there cloning many posters here; pic, profile, and tweaking, or adding one letter, or number in the profile name. Someone with too much time on their hands. Be mindful when receiving ‘following’ notifications or private messages from this individual.
8 · Reply
SeniorVip
SeniorVip Jul. 19 at 3:01 PM
$IBRX In order for this stock to moon and stay mooned and not fading, the following needs to happen: 1) strong revenue that increases quarter over quarter and year over year. 2) control of expenses 3) no more dilution to cover expenses. Dilution to cover revenue generating expenses may be acceptable 4) Institutional investors that buy/bought on the cheap 5) after #1, 2 & 4 are complete, the institutional investors will drive the stock price higher by multiple folds and keeps it up for years To be clear, retailer investors/traders can not drive the stock price higher and keep pushing it higher and keep it high. They may be able to squeeze it but it will eventually fade. The next opportunity is the next ER.
1 · Reply
Willie3000
Willie3000 Jul. 19 at 3:00 PM
$IBRX here's the updated response from IBRX on requesting EAP for my GFs Mom's AML... I'm paraphrasing due to a confidentiality notice on their email: clinical trials (only) would be available based on her having AML. And there aren't any available for that diagnosis right now. It's ok -and we tried. But we are pleased with the personalized and timely response from Immunity Bio, even though we were hoping for different. I'd commend Sandy Brady, Patient Care Coordinator, for her prompt attention.... considering they probably get 100s of these every day. Willie
1 · Reply
KMA3
KMA3 Jul. 19 at 2:36 PM
$IBRX hope they go w that marketing: ""general purpose" mRNA jab" the response will be fun to watch
1 · Reply
LadyQRex
LadyQRex Jul. 19 at 2:34 PM
$IBRX - Good morning. Someone is spoofing accounts and asking, “How are your trades going?” I report and block as these are scammers. If you receive a follow from me and there are no posts associated with my profile, it’s a fake.
0 · Reply
cvomark
cvomark Jul. 19 at 2:09 PM
$IBRX I’m thinking this reinforces PSS thesis that boosting the immune system is the answer. Hope we have the best approach and get it going soon. This is from Scott Adam’s X post this morning. https://newatlas.com/cancer/universal-cancer-vaccine/ “Keep it Continue”
0 · Reply
Latest News on IBRX
ImmunityBio: Taking Care Of Business

Apr 3, 2025, 5:54 PM EDT - 3 months ago

ImmunityBio: Taking Care Of Business


ImmunityBio to Host Investor Day

Mar 26, 2025, 6:00 AM EDT - 4 months ago

ImmunityBio to Host Investor Day


ImmunityBio: Forging A New Plan After Recent $100 Million Offering

Dec 16, 2024, 12:24 AM EST - 7 months ago

ImmunityBio: Forging A New Plan After Recent $100 Million Offering


ImmunityBio Reports Third-Quarter 2024 Financial Results

Nov 12, 2024, 7:15 AM EST - 8 months ago

ImmunityBio Reports Third-Quarter 2024 Financial Results


Top 2 Health Care Stocks That May Fall Off A Cliff This Month

Oct 25, 2024, 8:22 AM EDT - 9 months ago

Top 2 Health Care Stocks That May Fall Off A Cliff This Month

SRRK


ImmunityBio: Moving The Needle

Oct 7, 2024, 11:18 AM EDT - 10 months ago

ImmunityBio: Moving The Needle


ImmunityBio: Anktiva Launch, Good Data, Low Cash, High Debt

Sep 21, 2024, 7:02 PM EDT - 10 months ago

ImmunityBio: Anktiva Launch, Good Data, Low Cash, High Debt


Top 3 Health Care Stocks That Are Set To Fly This Quarter

Aug 16, 2024, 7:57 AM EDT - 1 year ago

Top 3 Health Care Stocks That Are Set To Fly This Quarter

HAE PGNY


arnolddunn
arnolddunn Jul. 19 at 6:16 PM
$IBRX guess bulls have been spoofing each other a long time.
0 · Reply
david756
david756 Jul. 19 at 5:30 PM
$NLST Same crap going on with shorts coping accounts and following on the $IBRX board
0 · Reply
BixbyKnolls
BixbyKnolls Jul. 19 at 4:57 PM
$IBRX Perhaps BioShield can save healthcare in our country. Conservative IBD. Going to hurt the maga base along with many of us? https://www.investors.com/news/big-beautiful-bill-trump-budget-health-care-coverage/
0 · Reply
John_morris
John_morris Jul. 19 at 3:30 PM
$IBRX Sharing https://x.com/GretchMick/status/1946578408399651138
1 · Reply
Jhankster60
Jhankster60 Jul. 19 at 3:25 PM
$IBRX There’s an imposter out there cloning many posters here; pic, profile, and tweaking, or adding one letter, or number in the profile name. Someone with too much time on their hands. Be mindful when receiving ‘following’ notifications or private messages from this individual.
8 · Reply
SeniorVip
SeniorVip Jul. 19 at 3:01 PM
$IBRX In order for this stock to moon and stay mooned and not fading, the following needs to happen: 1) strong revenue that increases quarter over quarter and year over year. 2) control of expenses 3) no more dilution to cover expenses. Dilution to cover revenue generating expenses may be acceptable 4) Institutional investors that buy/bought on the cheap 5) after #1, 2 & 4 are complete, the institutional investors will drive the stock price higher by multiple folds and keeps it up for years To be clear, retailer investors/traders can not drive the stock price higher and keep pushing it higher and keep it high. They may be able to squeeze it but it will eventually fade. The next opportunity is the next ER.
1 · Reply
Willie3000
Willie3000 Jul. 19 at 3:00 PM
$IBRX here's the updated response from IBRX on requesting EAP for my GFs Mom's AML... I'm paraphrasing due to a confidentiality notice on their email: clinical trials (only) would be available based on her having AML. And there aren't any available for that diagnosis right now. It's ok -and we tried. But we are pleased with the personalized and timely response from Immunity Bio, even though we were hoping for different. I'd commend Sandy Brady, Patient Care Coordinator, for her prompt attention.... considering they probably get 100s of these every day. Willie
1 · Reply
KMA3
KMA3 Jul. 19 at 2:36 PM
$IBRX hope they go w that marketing: ""general purpose" mRNA jab" the response will be fun to watch
1 · Reply
LadyQRex
LadyQRex Jul. 19 at 2:34 PM
$IBRX - Good morning. Someone is spoofing accounts and asking, “How are your trades going?” I report and block as these are scammers. If you receive a follow from me and there are no posts associated with my profile, it’s a fake.
0 · Reply
cvomark
cvomark Jul. 19 at 2:09 PM
$IBRX I’m thinking this reinforces PSS thesis that boosting the immune system is the answer. Hope we have the best approach and get it going soon. This is from Scott Adam’s X post this morning. https://newatlas.com/cancer/universal-cancer-vaccine/ “Keep it Continue”
0 · Reply
BixbyKnolls
BixbyKnolls Jul. 19 at 1:25 PM
$IBRX PSS " Sadly, know you may be calling into the clinic, but its just impossible for us. I want this across the country." (BIoShield) With prostrate cancer patient, Mark Halperin, Senator Bill Cassidy. https://www.youtube.com/live/m0VrBD9xRSU?si=Qzy5LvgZF0Hc_KdM
0 · Reply
listenteme
listenteme Jul. 19 at 1:08 PM
$IBRX BYE BYE to the July calls maybe august will be better.
0 · Reply
IBRXrallypossum002100
IBRXrallypossum002100 Jul. 19 at 12:56 PM
$IBRX lots of ppl got hacked i think
1 · Reply
arnolddunn
arnolddunn Jul. 19 at 12:55 PM
$IBRX the more you see bullish rants …usually time to run the other way…the rants mostly the same people…who r consistently wrong.
1 · Reply
FlipStink
FlipStink Jul. 19 at 12:40 PM
$IBRX Congress should pass a law that forbids a company from selling or profiting from a “cure” for a product they sold to the victim/patient
1 · Reply
danp5648
danp5648 Jul. 19 at 11:53 AM
$IBRX My march to a million using long term buy and hold "trading" .. $AMPX $QS $HCWB $IBRX Day 2 Total Value $462,589.73 Day Change +$4,884.88 (+1.07%) YTD Change +$79,845.08 (+20.86%) Day 1 Total Value $457,727.00 Day Change +$13,342.30 (+3.04%) YTD Change +$74,982.35 (+19.59%)
0 · Reply
YeboGogo
YeboGogo Jul. 19 at 9:54 AM
$IBRX the most undervalued stock on planet earth right now. WHEN YOU KNOW, YOU KNOW! Upcoming catalysts: > Q2 sales update > financial details of Saudi deal > EMA approval of Anktiva for NMIBC > landmark FDA announcement to expedite Anktiva trials in other indications / increase Anktiva's market penetration (not if, when - if you think otherwise, you have not been paying attention)
2 · Reply
Trina1954
Trina1954 Jul. 19 at 2:56 AM
$IBRX We need this E Jackson to start cheerleading on IBRX https://www.cnbc.com/2025/07/18/eric-jackson-opendoor-real-estate-carvana.html
1 · Reply
John_morris
John_morris Jul. 18 at 10:47 PM
$IBRX Sharing - EMA process(latest update) Seems that IBRX has still not answered the LoQ (List of Questions) in the EMA process - meaning, Stop Clock #1 ongoing. See row 85 - last column I ( Restart after LoQ) is still Blank. (Or if you are over-optimistic then there are no questions in the first place - I doubt that is the case). Report as of July 18, 2025. Applications for new human medicines under evaluation: July 2025 https://www.ema.europa.eu/en/medicines/medicines-human-use-under-evaluation Let us wait for the CHMP meeting July 21-24 to see if there is anything related to Anktiva.
7 · Reply
TheWinningStock
TheWinningStock Jul. 18 at 10:20 PM
1 · Reply
Trina1954
Trina1954 Jul. 18 at 10:02 PM
$IBRX We should contact this Hedge fund manager, Eric Jackson with EMJ Capital. He started cheerleading on OPEN, now about 200 percent from under $1 and he said his goal for OPEN to reach $80 plus per share. He did that with CVNA from $4 now $345.
2 · Reply
johnnyta
johnnyta Jul. 18 at 9:48 PM
$IBRX looks like the whole sector got spooked by $SRPT decision.
2 · Reply